Peptide Therapeutics
Brian Fish and Glenn Mattison
Opening the Topic: Why Peptides Matter Now
Peptide therapeutics have become an increasingly visible part of modern medicine and public health culture. Some peptide-based treatments are FDA-approved and clinically established, while others remain under investigation or circulate in gray-area consumer spaces, especially online. As a result, peptides are often discussed as though they belong to one broad category, even when their scientific support, clinical validation, and regulatory status differ significantly.
Explaing the Purpose of Our Website
This website was created to make those distinctions easier to understand. Rather than treating all peptides as part of the same conversation, it organizes the topic across several connected areas: what peptides are biologically, how they are developed as therapies, how they are classified in medicine and regulation, how selected compounds compare, and how public discussion, especially through digital culture, can shape the way they are interpreted.
Stating Our Goal
The goal of this project is not simply to define peptides, but to explain why they matter across different settings and why clear communication about them has become increasingly important.
Framing the Website as More Than Biology
This site presents peptide therapeutics as more than a biomedical topic. It also examines them as regulatory issues, communication challenges, and cultural objects shaped by the way information moves through public life.
Connect with us
Our location
Tuscaloosa, Alabama, United States
For inquiries, please contact us: